Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission-Reference-Cited by-同舟云学术

Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission

Published:2015-11-06 Issue:11 Volume:2015 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Mao Chen¹,Fu Xiao-Hong¹,Yuan Jin-Qiu¹,Yang Zu-Yao¹,Huang Ya-Fang¹,YE Qian-Ling²,Wu Xin-Yin¹,Hu Xue-Feng¹,Zhai Zhi-Min²,Tang Jin-Ling¹

Affiliation:

1. The Chinese University of Hong Kong; Division of Epidemiology, The Jockey Club School of Public Health and Primary Care; Hong Kong SAR China

2. The Second Hospital of Anhui Medical University; Department of Haematology; No. 678, Furong Rd., Economic and Technological Development Zone Hefei Anhui China 230601

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD010248.pub2/fullpdf

Reference69 articles.

1. Low-dose interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720;Baer;Journal of Clinical Oncology,2008

2. Randomized study of recombinant interleukin-2 after autologous bone marrow transplantation for acute leukemia in first complete remission;Blaise;European Cytokine Network,2000

3. Low-dose interleukin-2 in AML in first remission - A multicenter randomized study [abstract];Faber;Blood,1997

4. Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: results from Cancer and Leukemia Group B 19808;Kolitz;Cancer,2014

5. P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808;Kolitz;Blood,2010

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maintenance therapy in acute myeloid leukemia: advances and controversies;Haematologica;2023-05-04

2. SOHO State of the Art Updates and Next Questions |The Role of Maintenance Therapy in Acute Myeloid Leukemia;Clinical Lymphoma Myeloma and Leukemia;2023-01

3. A retrospective study on effectiveness of combined recombinant human interferon-α-1b, interleukin-2, and thalidomide for the treatment of acute myeloid leukemia in various disease states;Annals of Translational Medicine;2022-12

4. Targeted and cytotoxic therapies as maintenance treatment for non-transplant eligible patients with acute myeloid leukemia;Blood Reviews;2021-11

5. AML and the art of remission maintenance;Blood Reviews;2021-09